EU pediatric rules five years on: "culture change", but results still patchy
This article was originally published in Scrip
Executive Summary
The EU's Paediatric Regulation has effected a "culture change" in Europe, to the extent that pharmaceutical companies have come to see clinical trials in children as an integral part of drug development, and the authorities now have a large amount of hitherto unpublished and valuable pediatric trial data at their disposal.